Literature DB >> 24080741

α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models.

Judith Eschbach1, Karin M Danzer.   

Abstract

Parkinson's disease is a common neurodegenerative disease characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta and the formation of α-synuclein aggregates found in Lewy bodies throughout the brain. Several α-synuclein transgenic mouse models have been generated, as well as viral-mediated overexpression of wild-type and mutated α-synuclein to mimic the disease and to delineate the pathogenic pathway of α-synuclein-mediated toxicity and neurodegeneration. In this review, we will recapitulate what we have learned about the function of α-synuclein and α-synuclein-mediated toxicity through studies of transgenic animal models, inducible animal models and viral-based models. 2013 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24080741     DOI: 10.1159/000354615

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  12 in total

1.  Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.

Authors:  Chong-Bin Zhong; Qian-Qian Chen; Caroline Haikal; Wen Li; Alexander Svanbergsson; Meike Diepenbroek; Jia-Yi Li
Journal:  Neurosci Bull       Date:  2017-09-18       Impact factor: 5.203

2.  α-Synuclein activates innate immunity but suppresses interferon-γ expression in murine astrocytes.

Authors:  Jintang Wang; Zheng Chen; Jeremy D Walston; Peisong Gao; Maolong Gao; Sean X Leng
Journal:  Eur J Neurosci       Date:  2018-05-19       Impact factor: 3.386

3.  The dual role of c-src in cell-to-cell transmission of α-synuclein.

Authors:  Yu Ree Choi; Jae-Bong Kim; Seo-Jun Kang; Hye Rin Noh; Ilo Jou; Eun-Hye Joe; Sang Myun Park
Journal:  EMBO Rep       Date:  2020-05-05       Impact factor: 8.807

4.  A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson's disease.

Authors:  Hui-Qing Zhao; Fang-Fei Li; Zhan Wang; Xue-Mei Wang; Tao Feng
Journal:  Neurol Sci       Date:  2016-02-01       Impact factor: 3.307

Review 5.  Interactions between calcium and alpha-synuclein in neurodegeneration.

Authors:  Alex Rcom-H'cheo-Gauthier; Jacob Goodwin; Dean L Pountney
Journal:  Biomolecules       Date:  2014-08-14

Review 6.  Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies.

Authors:  Alexandre N Rcom-H'cheo-Gauthier; Samantha L Osborne; Adrian C B Meedeniya; Dean L Pountney
Journal:  Front Neurosci       Date:  2016-12-20       Impact factor: 4.677

Review 7.  Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention.

Authors:  Sara A Ferreira; Marina Romero-Ramos
Journal:  Front Cell Neurosci       Date:  2018-08-06       Impact factor: 5.505

8.  Synuclein Deficiency Results in Age-Related Respiratory and Cardiovascular Dysfunctions in Mice.

Authors:  Patrick S Hosford; Natalia Ninkina; Vladimir L Buchman; Jeffrey C Smith; Nephtali Marina; Shahriar SheikhBahaei
Journal:  Brain Sci       Date:  2020-08-24

9.  The expression of KATP channel subunits in alpha-synuclein-transfected MES23.5 cells.

Authors:  Shuai-Shuai Han; Qian Jiao; Ming-Xia Bi; Xi-Xun Du; Hong Jiang
Journal:  Ann Transl Med       Date:  2018-05

10.  Inducible and combinatorial gene manipulation in mouse brain.

Authors:  Godwin K Dogbevia; Ricardo Marticorena-Alvarez; Melanie Bausen; Rolf Sprengel; Mazahir T Hasan
Journal:  Front Cell Neurosci       Date:  2015-04-21       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.